PAVmed Inc. Common Stock
PAVMStock
$6.02−64.51%52W
Market Cap$43.17M
P/E107.66x
Div yield—
Beta0.54
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-26.80%
Price vs S&P 500 (4W)21.77%
VGM Score39.69
Market Capitalization$43.17M
P/E Ratio (Annual)107.66x
Earnings Surprise History
Q1 26-4.42est. -0.71
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.13
4.13
4.13
4.13
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
PAVMPAVmed Inc. Common Stock | D | C | D | $6.02 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
PAVmed Inc is a commercial-stage medical technology company developing products across diagnostics, medical devices, and digital health. Its portfolio includes EsoGuard, esocheck, and the Veris Cancer Care Platform. The company is advancing its pipeline through commercialization to serve multiple healthcare markets.